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The aim of this present study was to evaluate the immune functions and immune responses in nicotine-induced (10mM)
macrophages and concurrently establish the immunomodulatory role of aqueous extract of Ocimum gratissimum (Ae-Og) and
ascorbic acid. In this study, nitrite generations and some phenotype functions by macrophages were studied. Beside that, release
of Th1 cytokines (TNF-α, IL-12) and Th2 cytokines (IL-10, TGF-β) was measured by ELISA, and the expression of these cytokines
at mRNA level was analyzed by real-time PCR. Ae-Og, at a dose of 10μg/mL, signiﬁcantly reduced the nicotine-induced NO
generation and iNOSIIexpression. Similar kindsofresponsewereobserved with supplementation ofascorbicacid (0.01mM).The
administration of Ae-Og and ascorbic acid increased the decreased adherence, chemotaxis, phagocytosis, and intracellular killing
of bacteria in nicotine-treated macrophages. Ae-Og and ascorbic acid were found to protect the murine peritoneal macrophages
through downregulation of Th1 cytokines in nicotine-treated macrophages with concurrent activation of Th2 responses. These
ﬁndings strongly enhanced our understanding of the molecular mechanism leading to nicotine-induced suppression of immune
functions and provide additional rationale for application of anti-inﬂammatory therapeutic approaches by O. gratissimum and
ascorbic acid for diﬀerent inﬂammatory disease prevention and treatment during nicotine toxicity.
1.Introduction
Herbal remedies are demanding approach to treat several
inadequate conditions of public health. In our previous lab
report, aqueous extract and methanol extract of Ocimum
gratissimum Linn protect nicotine-induced cellular damage
in murine macrophages [1, 2]. But, the immunomodulatory
role of aqueous extract of O. gratissimum against nicotine
toxicity in murine macrophages has not been enlightened
yet. O. gratissimum is an important medicinal herb, com-
monly known as “Ram Tulshi” in India. This plant belongs
to the “Labiaceae” plant family member. The plant is used in
folk medicine to treat diﬀerent common diseases like cold
and ﬂues [3, 4]. The fresh juice of O. gratissimum leaves
is used as a mouth antiseptic. It has been associated with
chemopreventive, anticarcinogenic, free radical scavenging,
radio protective, and numerous others pharmacological use
[5]. The aqueous leaf extract and seed oil showed anti-
proliferative and chemopreventive activity on HeLa cells [6].
Ascorbic acid (AA) is used as beneﬁcial in common
medicine practice. AA plays an important role in the
defense against oxidative damage, owing to its function as
a reducing agent [7]. Moreover, ascorbic acid participates
in the modulation of complex biochemical pathways that
are an essential part of the normal metabolism of immune
cell [8]. Mechanistic studies indicated that ascorbic acid can
modulate the immune system by inhibiting FAS-induced
monocyte apoptosis [9]. Ascorbic acid enhances the human
immune response that enhances the Con A-induced prolif-
eration of PBLs [10], chemotaxis of neutrophils [11], and
phagocytosis of mononuclear leukocytes [12]. It has been
reported that ascorbic acid upregulates the IgM antibody
responses in a cytokine-dependent manner in spleenocytes
[13]. The in vitro function of endotoxic shock-induced2 Oxidative Medicine and Cellular Longevity
macrophages and lymphocytes was modulated by ascorbic
acid [14, 15]. It also suppressed the immunobiological path-
ways and exerts anti-inﬂammatory activity in unstimulated
and mitogen-stimulated peripheral blood mononuclear cells
in vitro [16]. In a current study, Chang et al. reported that
high dose of AA supplementation might attenuate allergic
inﬂammation in vivo via modulating the Th1/Th2 balance
toward the Th1 pole during the Th2-skewed allergic air-
way inﬂammation and decreasing eosinophilic inﬁltration
into BALF [17]. Hence, the use of ascorbic acid (as a
reference drug) to protect the adverse eﬀect of nicotine in
murine peritoneal macrophages may bring a therapeutic ap-
proach.
The inﬂammatory system is kept in balance through the
reciprocal production of predominantly proinﬂammatory
cytokines, including tumor necrosis factor-alpha (TNF-α)
from T helper 1 (Th1) cells, and predominantly anti-
inﬂammatory cytokines, including interleukin 10 (IL-10)
from (primarily) T helper 2 (Th2) cells [18, 19]. This balance
of pro- to anti-inﬂammatory cytokines is described as a ratio
of Th1/Th2 type responses elsewhere [20, 21]. Macrophages
are both antigen presenting cells and phagocytes and exert
eﬀects, for example, by production of cytokines like IL-12,
TNF-α,a n dI F N - γ [22]. By secreting IL-12, they regulate
the Th1/Th2 cytokine balance toward a Th1-proﬁle. Fur-
thermore, macrophage secretion of cytokines might provoke
free radical production [23]. Th1 cells predominantly secrete
TNF-α and IL-12, whereas Th2 cells mainly release IL-
10. There are also Th3 cells, producing TGF-β, that act as
regulators of eﬀector T cells [24].
Nicotine, the major toxic product of cigarette smoke
and other tobacco products, has been implicated in the
development of free radical mediated oxidative injury in
murineperitonealmacrophages,lymphocytes,andalbinorat
tissues [25–28]. Cigarette smoke, the main source of nicotine
exposure in human health, is a major health risk factor
worldwideandsigniﬁcantlyincreasestheincidenceofseveral
diseases. Many of these diseases are inﬂammatory in nature
or have an inﬂammatory component. Nicotine has been
showntosuppressvariousparametersoftheimmunesystem.
Downregulation of IL-10 release and mRNA expression by
nicotine has been observed experimentally using a murine
alveolarmacrophagecellline[29],andIL-6,TNF-α,andIFN
γ are released in LPS-induced murine spleenocyte [30].
In this present study, we have hypothesized that nicotine-
induced alteration of the cellular functions and Th1/Th2
cytokines production in murine macrophages may be ame-
liorated through administration of O. gratissimum products.
To our knowledge, there are no comprehensive studies
available on this particular issue. Hence, we have approached
the anti-inﬂammatory/beneﬁcial role of O. gratissimum and
ascorbic acid to restore the macrophage functions and
Th1/Th2 cytokine balance in it.
2. Results
2.1. Nitrite Generation by Macrophages. We have studied
the nicotine-induced nitrite generation in murine peritoneal
macrophages in presence of Ae-Og/ascorbic acid by Griess
reagent (Figure 1(a)). NO generation is signiﬁcantly (P<
0.05) increased in nicotine-treated macrophage by 2.81-
fold in comparison to control macrophages, which was also
signiﬁcantly (P<0.05) ameliorated by coadministration
of Ae-Og, and ascorbic acid with nicotine. To conﬁrm the
NO release, we have also studied the iNOSII expression
at mRNA level after treatment schedule. We have found
that iNOSII expression at the mRNA level was signiﬁcantly
(P<0.05) increased by 3.02-fold in nicotine-treated cell,
supplementation of Ae-Og and ascorbic acid can reduce the
iNOSII expression signiﬁcantly (P<0.05) compared to
nicotine-treated group and these are toward the control level
(Figures 1(b) and 1(c)). Hence, Ae-Og, a naturally occurring
plant product, can reduce the nitrite generation like ascorbic
acid in nicotine-treated murine peritoneal macrophage.
2.2.StudyofMacrophageFunctionduetoNicotine,Ae-Og,and
Ascorbic Acid Treatment. The cellular functions of peritoneal
macrophages at 15, 30, 60, and 90min after treatment
schedule are shown in Figure 2. The adherence indexes
(Figure 2(a)), chemotactic indexes (Figure 2(b)), phagocy-
tosis indexes (Figure 2(c)) were increased in all groups of
macrophages in time-dependent fashion. These indexes were
decreased in nicotine-treated group showing statistically
signiﬁcant diﬀerences (P<0.05) at each time interval with
respect to the control group of peritoneal macrophages. But,
these were increased signiﬁcantly (P<0.05) with supple-
mentation of Ae-Og and ascorbic acid compared with only
nicotine-treated group at each time interval. The intracellu-
lar killing of S. aureus at diﬀerent time point by untreated
and treated peritoneal macrophages was estimated to deter-
mine the intracellular killing property of macrophages
(Figure 2(d)). The percentage of viable S. aureus at initial
point was 100, which was decreased with increasing time in
all types of treatment. The viability of bacteria was decreased
at 15min time point, but it was increased from 30min to
end point of the studied interval than normal macrophage.
The percentages of viable bacteria were gradually decreased
in normal, nicotine + Ae-Og, and nicotine + ascorbic acid-
treated group at each time point of studied interval.
2.3. Eﬀect of Nicotine, Ae-Og, and Ascorbic Acid on Cytokine
Production. It is well established that nicotine is an inﬂam-
matory drug that regulates the immunological functions.
Hence,weplannedtostudywhetherAe-Ogandascorbicacid
treatment could modulate proinﬂammatory cytokine (TNF-
α and IL-12) and anti-inﬂammatory cytokine (TGF-β,I L -
10) release and expression at mRNA level in treated murine
peritoneal macrophages. We observed that treatment with
nicotine in macrophages showed signiﬁcant increase in the
release of TNF-α and IL-12p70 in comparison with control
cells, which was signiﬁcantly decreased with supplementa-
tion of Ae-Og and ascorbic acid (Figures 3(a) and 3(b)). The
signiﬁcantincreaseinTNF-αreleasemightplayapivotalrole
in triggering the signal for enhanced NO generation. On the
other hand, the release of TGF-β and IL-10, the signature
anti-inﬂammatory cytokines, was signiﬁcantly decreased
upon nicotine treatment. Coadministration of Ae-Og andOxidative Medicine and Cellular Longevity 3
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Figure 1: Eﬀects of nicotine (10mM), aqueous extract (Ae-Og) (10μg/mL), and ascorbic acid (AA) (0.01mM) on nitrite (NO) generation
and iNOSII expression in murine peritoneal macrophages are presented in Figure 1. Macrophages were treated with nicotine, nicotine +
Ae-Og, and nicotine + AA. After the treatment schedule, as mentioned in Section 4, cell-free supernatants collected were subjected to the
(a) nitrite generation spectrophotometrically by the Griess reaction and expressed as (μM). (b) The expression levels of iNOSII mRNA
transcripts in murine peritoneal macrophages were measured by quantitative real-time PCR. (c) Data, obtained from RT-PCR, are presented
alsoasfoldchangesofiNOSIIexpressioncomparedwithnormalmacrophages.Alltheexperimentalresultsarepresentedasmean ±S.E.Mof
data obtained from three independent experiments that yielded similar results. “∗” indicates statistically signiﬁcant (P<0.05) induction of
nitrite generation and iNOSII expression in nicotine-treated cell compared with control and “#” indicates statistically signiﬁcant (P<0.05)
decrease of nitrite generation as well as iNOSII expression in Ae-Og and AA-supplemented macrophages compared with nicotine-treated
macrophages.
ascorbic acid with nicotine (Figures 3(c) and 3(d)) signiﬁ-
cantly increases the release of these two anti-inﬂammatory
cytokines. To conﬁrm our quantitative data, as observed by
the ELISA method, we further studied the mRNA expression
of the above cytokines after the treatment schedule by using
real-time PCR analysis. The results revealed that, there was
a signiﬁcant increase of TNF-α (Figures 3(e) and 3(f)) and
IL-12p40 (Figures 3(e) and 3(g)) expression in the nicotine-
treated macrophages compared with control macrophages.
Macrophages treated with nicotine in combination with Ae-
Og/ascorbic acid showed a signiﬁcant decrease in the expres-
sion levels of TNF-α and IL-12p40, compared with nicotine-
treated macrophages. On the other hand, in nicotine-treated
macrophages, there was a signiﬁcant decrease of TGF-β
(Figures 3(e) and 3(h)) and IL-10 (Figures 3(e) and 3(i)) in
comparison with control macrophages at the mRNA level.
When macrophages were treated with nicotine along with
Ae-Og/ascorbic acid, the expression of TGF-β and IL-104 Oxidative Medicine and Cellular Longevity
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Figure 2: Eﬀects of nicotine (N) (10mM), aqueous extract (Ae-Og) (10μg/mL), and ascorbic acid (AA) (0.01mM) on (a) adherence
index, (b) chemotactic index, (c) phagocytic index, and (d) intracellular killing property of murine peritoneal macrophages are presented
in Figure 2. After the treatment schedule, as mentioned in Section 4, the cells were collected and the functions of murine peritoneal
macrophages were observed. Nicotine-treated cells showed the signiﬁcant (P<0.05) decreased functional activity in time-dependent
manner, which were signiﬁcantly increased during supplementation of Ae-Og and ascorbic acid. All the experimental results are presented
as mean ± S.E.M of data obtained from three independent experiments that yielded similar results. “∗” indicates statistically signiﬁcant
(P<0.05) diﬀerence of in nicotine-exposed macrophages compared with control and “#” indicates statistically signiﬁcant (P<0.05)
diﬀerence in Ae-Og and ascorbic acid supplemented macrophages compared with nicotine-treated macrophages.
was signiﬁcantly increased in comparison with nicotine-
treated macrophages. It is the balance between the Th1 and
Th2 cytokines that determines the susceptibility of diﬀerent
immunological disorders [31]. Our present ﬁndings showed
that nicotine-treated macrophages induce Th1 cytokines and
suppressed Th2 cytokines and, following treatment with
Ae-Og and ascorbic acid in nicotine-treated macrophages,
suppress the Th1 cytokines and enhance the Th2 cytokines,
thereby preventing the vulnerability of immune disorder.
3. Discussion
The use of biologically active natural products is gaining
increasing popularity day by day over traditional medicine
as a striking alternative for the treatment of various diseases.
O. gratissimum has been used for the medicinal purposes
from the ancient ages, and recently we have found a number
of beneﬁcial roles against nicotine-induced toxicity in
murine peritoneal macrophages [1, 6, 32, 33]. In this presentOxidative Medicine and Cellular Longevity 5
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Figure 3: Eﬀects of nicotine (10mM), aqueous extract (Ae-Og) (10μg/mL), and ascorbic acid (AA) (0.01mM) on cytokine proﬁles in
murine peritoneal macrophages at protein and mRNA levels are presented in this ﬁgure. After the treatment schedule the cells and the
cell-free supernatants were collected separately. The levels of (a) TNF-α (pg/mL), (b) IL-12p70 (pg/mL), (c) TGF-β (pg/mL), and (d) IL-
10 (pg/mL) in the culture supernatant were evaluated by sandwich ELISA. The cells were dissolved in TRIZOL for mRNA extraction and
analyzed using real-time PCR to study diﬀerent proinﬂammatory and anti-inﬂammatory cytokine mRNA expressions. Quantitative real-
time PCR results (e) show the expression of studied cytokines and the data are presented as fold changes compared with the control cells as
follows: (f) TNF-α, (g) IL-12p40, (h) TGF-β, and (i) IL-10 mRNA. Results are expressed as means ± S.E.M. from three replicate experiments
yielding similar results. “∗” indicates statistically signiﬁcant (P<0.05) diﬀerence of in nicotine-exposed macrophages compared with
control,and“#”indicatestatisticallysigniﬁcant(P<0.05)diﬀerenceinAe-OgandAA-supplementedmacrophagescomparedwithnicotine-
treated macrophages.6 Oxidative Medicine and Cellular Longevity
study, we have demonstrated that in vitro treatment with
O. gratissimum product (Ae-Og) signiﬁcantly reduced the
nicotine-induced nitrite generation in murine peritoneal
macrophages (Figure 1(a)).
Peritoneal macrophages play an essential role in the
immune response of the host to inﬂammatory and infectious
processes. In the present study, we have examined some
of the cellular activities of macrophages like cell adhesion,
chemotactic migration, phagocytosis, intracellular killing
assay, and proinﬂammatory and anti-inﬂammatory cytokine
release to demonstrate the protective measures of Ae-Og
and ascorbic acid against nicotine-induced modulation of
cellular activities. Phagocytosis by inﬂammatory cells is an
essential step and a part of innate immunity to protect
against foreign pathogens and microorganisms or remove
dead cells. The ﬁrst step of phagocytosis involves adherence
of phagocytic cells to tissue substrate before migration of
these cells to the site of inﬂammation. This requires the
macrophages recognition and adheres strongly enough so
that they are not swept away by the ﬂowing blood. In vitro
cell adhesion assay may reﬂect the in vivo capacity of cellular
adherence. Adhesion of macrophages shows a marked reduc-
tion in a time-dependent manner after nicotine intoxication
(Figure 2(a)). Chemotactic index was signiﬁcantly decreased
in that of nicotine-exposed cells (Figure 2(b)). Hence it can
besuggestedthatnicotineintoxicationmaysomehowchange
the shape and functionally inactivate the macrophages, so
that they migrated at a slower rate toward the chemotactic
agent (fMLP). Phagocytosis is an important determinant of
immune cell function. Although, free radical generation was
found in higher level in nicotine-induced murine peritoneal
macrophage in concentration and time-dependent manner
[25, 26], in this present study, we have found that the
phagocytic index and intracellular killing of bacteria were
signiﬁcantly decreased in nicotine-treated cell compared
with control group (Figures 2(c) and 2(d)). In support of
our results, many researchers had reported the decreased
phagocytic and bactericidal activity by alveolar macrophages
of smoker [34–36]. Besides that, in our present study,
these phenotype functions (adherence capacity, chemotactic
property, rate of phagocytosis, and intracellular killing) were
signiﬁcantly increased in time-dependent way due to supple-
mentation of Ae-Og and ascorbic acid (Figure 2). It may be
due to the eﬀect of this bioactive principle of O. gratissimum
and ascorbic acid to protect murine peritoneal macrophage
from deleterious eﬀect of nicotine and, simultaneously, help
to restore their normal functions. So, the natural product
(Ae-Og) and potent antioxidant, ascorbic acid, may be used
as immune modulator drug in current future.
We have found that nicotine augments the secretion of
proinﬂammatory cytokines and iNOSII expression in mu-
rine macrophages. The novel ﬁnding that nicotine augments
proinﬂammatory cytokine response in macro-phages may
explain the molecular mechanism of nicotine-augmented
immune disorder in this in vitro model. Nicotine may
directly induce iNOSII and TNF-α expression in macro-
phages via the nicotinic acetylcholine receptors. In turn, the
activated macrophages, after they inﬁltrate the lesion, may
activate the NF-κB transcriptional factor in macrophages
withtheirsecretedproinﬂammatorycytokinesandgenerated
oxidative stress [37]. The simultaneous increase of free
radical facilitates the progression of diﬀerent immune
disorder. The role of NO in immune-mediated diseases is
controversial [38–40]. The free radical NO directly mediates
tissue destruction[38,41],and otherﬁndings suggesta more
modulatory role for NO in inﬂammation. Furthermore, it
has been suggested that NO modulates the Th1/Th2 balance
by favoring Th1 responses [39, 40]. In this study, nicotine
induces NO generation (Figure 1(a)) in murine peritoneal
macrophages as well as iNOSII expression in mRNA level
was downregulated when the cells were supplemented with
Ae-Og or ascorbic acid in presence of nicotine (Figures 1(b)
and 1(c)). So, the herbal product (Ae-Og) and ascorbic
acid inhibit the NO production during nicotine toxicity in
murine peritoneal macrophages.
Macrophages represent the major source of cytokines;
these are susceptible to regulate multiple functions of the
macrophages. But, the immune regulatory role of nicotine
onmacrophageshasnotbeenfullyclariﬁed,andthereported
data are often conﬂicting, especially on the eﬀects of nicotine
on cytokine production [29, 30, 42, 43]. Our ﬁnding of the
toxic eﬀect of nicotine is in agreement with the observation
that nicotine can regulate the expression of chemokines
like TNF-α, IL-12, TGF-β,a n dI L - 1 2( Figure 3). Therefore,
nicotine alters the secretion of chemical mediators of inﬂam-
mation and reduces macrophage activity [44]. It was also
reported by Maes et al. that the ratio of Th1/Th2 responders
has been shown to be more indicative of immune function
[21].Inourpresentstudy,itiswelldocumentedthatnicotine
can trigger the Th1 cytokines (TNF-α and IL-12) and dimin-
ish the Th2 (TGF-β and IL-10) cytokine release (Figures
3(a)–3(d)) as well as in the mRNA level (Figures 3(e)–3(i)),
indicating that nicotine may have at least short-term damag-
ing eﬀect on the normal immune balance. The lack of a Th2
response to counter the increased Th1 response in nicotine-
exposed murine peritoneal macrophages suggests that nico-
tine, important ingredient of cigarette smoking, disrupts the
normal healthy balance of the Th1/Th2 levels resulting in
a higher vulnerability for normal cells to be at a greater
risk for developing certain autoimmune disorders. These
preliminary results may indicate the mechanism by which
nicotine increases disease vulnerability. Beside that, we have
also demonstrated the importance of Ae-Og and ascorbic
acidtoexertanewanti-inﬂammatorydrugtocombatagainst
nicotine-induced immune disorder; our results clearly estab-
lished that cotreatment of Ae-Og and ascorbic acid with
nicotine can diminish the nicotine-induced enhanced Th1
cytokines (TNF-α and IL-12) release and in mRNA level as
well as boost up the Th2 (IL-10 and TGF-β) cytokine release
and mRNA level up to more or less control level (Figure 3).
In our early reports, the nicotine-induced free radical
generation and oxidative damage are ameliorated by supple-
mentation of O. gratissimum plant products through de-
creasedfreeradicalgeneration(1,2,32).Itiswellknownthat
reactive oxygen species generation and its eﬀective oxidative
stress are involved in the regulation of redox-sensitive
transcription factors that mediate the expression of inﬂam-
matory mediators such as cytokines and chemokines. So, inOxidative Medicine and Cellular Longevity 7
the present study, anti-inﬂammatory therapeutic approaches
by O. gratissimum plant product may be directly/indirectly
protecting cell from adverse eﬀect of nicotine-induced
oxidative damage in murine peritoneal macrophages by
skewing the Th1 cytokines toward the Th2 cytokines.
In summary, our study has enhanced the understanding
ofthemolecularstepsleadingtonicotine-inducedweakening
of immune functions in murine macrophages and provided
additional rationale for the application of O. gratissimum
plant product and ascorbic acid as anti-inﬂammatory ther-
apeutic tools for diﬀerent inﬂammatory disease prevention
and treatment during nicotine toxicity.
4.MaterialsandMethods
4.1. Chemicals. Hydrogen tartarate salt of nicotine and
sodium dodecyl sulfate (SDS) were obtained from Sigma,
USA. RPMI 1640, fetal bovine serum (FBS), antibiotic
solutions(cellculturegrade),heparin,ethylenediaminetetra
acetate (EDTA), and ascorbic acid were purchased from
Himedia, India. ELISA assay Kit for tumour necrosis factor-
(TNF-) α, interleukin- (IL-) 12p70, IL-10, and transforming
growth factor- (TGF-) β (Quantikine M; R&D Systems,
Minneapolis, MN, USA) was procured. For isolation of total
RNA, TRI Reagent was purchased from Sigma, USA. dNTPs,
RevertAid M-MuLV Reverse Transcriptase, oligo dT, RNase
inhibitor, and other chemicals required for cDNA synthesis
were purchased from Fermentas, USA. Power SYBR Green
PCR Master Mix (X 2) for quantitative real-time PCR was
purchased from Applied Biosystems, UK. Oligos for real-
time PCR were purchased from Sigma, USA. All other
chemicalswerefromMerckLtd.,SRLPvt.Ltd.,Mumbai,and
were of the highest grade available.
4.2. Animals. Experiments were performed using Swiss male
mice 6–8 weeks old, weighing 20–25g. The animals were fed
standard pellet diet with vitamins, and antibiotic and water
were given ad libitum and housed in polypropylene cage
(Tarson) in departmental animal house with 12h light:dark
c y c l ea n dt h et e m p e r a t u r eo f2 5± 2◦C. The animals were
allowed to acclimatize for one week. The animals used
did not show any sign of malignancy or other patho-
logical processes. Animals were maintained in accordance
with the guidelines of the National Institute of Nutrition,
Indian Council of Medical Research, Hyderabad, India, and
approved by the ethical committee of Vidyasagar University.
4.3. Preparation of Aqueous Extract of Ocimum gratissimum .
O. gratissimum was collected from Midnapore, West Bengal,
India, in September 2007, in morning. Voucher specimens
were deposited at the herbarium of the Department of
Botany, Vidyasagar University. The fresh aerial part of O.
gratissimum was dried, blended, and extracted with double-
distilled water (10:1). The mixture was ﬁltered with What-
man ﬁlter paper (No. 1), concentrated at 38◦Cb yar o t a r y
evaporator, and then allowed to stand at room temperature
over night. The ﬁltration and concentration processes were
repeatedtoyieldanaqueoussolution.Thissolutionwasthen
centrifuged at 400×g for 10min and supernatant was freeze
dried to obtain the crude aqueous extract (Ae-Og) [1].
4.4. Preparation of Drug. Hydrogen tartarate salt of nicotine
(Sigma, USA) was dissolved in normal saline (0.9% NaCl)
to get the required concentration. The pH of the nicotine
solution was adjusted to 7.4 by NaOH [32]. The stock
solution of Ae-Og was diluted in normal saline to get the
required concentrations.
4.5. Isolation of the Peritoneal Macrophages and Cell Culture.
All eﬀorts were made to minimize animal suﬀering and
to reduce the number of animals used. Macrophages were
isolated by peritoneal lavage from male Swiss mice, after
24hrs injection of 2mL of 4% starch according to our
previous report [25]. Washing the peritoneal cavity with
ice cold phosphate buﬀer saline (PBS) supplemented with
20U/mL heparin and 1mM EDTA performed lavage. Care
was taken not to cause internal bleeding while collecting
macrophages in the exudates. The cells were then cultured
in 60mm petridishes in RPMI-1640 media supplemented
with 10%FBS, 50μg/mL gentamicin, 50μg/mL penicillin,
and 50μg/mL streptomycin for 24h at 37◦C in a humidiﬁed
atmosphere of 5% CO2/95% air in CO2 incubator. Nonad-
herent cells were removed by vigorously washing three times
with ice-cold PBS. Diﬀerential counts of the adherent cells
used for the experiments were determined microscopically
after staining with Giemsa and the cell viability evaluated by
Trypan blue exclusion was never below 95%.
4.6. Experimental Design. The peritoneal macrophages were
divided into 4 groups, containing 4 × 106 cells. The cells
of control and experimental groups were maintained in
RPMI 1640 media supplemented with 10%FBS, 50μg/mL
gentamycin,50μg/mLpenicillin,and50μg/mLstreptomycin
at 37◦C in a 95% air/5%CO2 atmosphere in CO2 incubator.
The following groups were considered for the experiment
and cultured for 12hrs: Group I: Control (culture media);
Group II: 10mM Nicotine in culture media; and Group
III: 10mM Nicotine + 10μg Ae-Og/mL culture media; and
Group IV: 10mM Nicotine + 0.01mM ascorbic acid in
culture media. The concentration of nicotine was selected
according to our previous lab report [25, 32], and the
concentration of ascorbic acid and Ae-Og was followed
according to our previous lab report [1].
4.7. Nicotine-Induced Nitrite Production (NO) in Murine
Macrophage. Nitrite production by murine macrophages
was measured spectrophotometrically by the Griess reaction
accordingtoourpreviouslabreport[33].Afterthetreatment
schedule, the cells were then centrifuged at 10,000rpm for
20min. The cell-free supernatants were transferred to sep-
arate microcentrifuge tube for nitric oxide release assay. To
100μL of each of the cell-free supernatant, 100μLo fG r i e s s
reagent (containing 1% sulfanilamide in 5% phosphoric acid
and 0.1% N-C-1 napthyl ethylene diamine dihydrochloride
in 1:1 ratio) was added and incubated in dark at room8 Oxidative Medicine and Cellular Longevity
temperature for 10min. Reading was taken in a UV spec-
trophotometer at 550nm and compared to a sodium nitrite
standard curve (values ranging between 0.5 and 25μM).
4.8. Determination of Adherence Index (AI). The quantiﬁca-
tion of adherence capacity was carried out by a method pre-
viously described [45]. After the experimental procedure,
aliquots of 200μL of peritoneal macrophages from group
were placed in eppendorf tubes and incubated at 37◦C. 10μL
cells were aspirated at 15, 30, 60, and 90min interval from
eppendrof tubes after gently shaking to resuspend the
sedimented cells, and the number of nonadhered macro-
phages was determined by counting in Neubauer chambers
(Blau Brand, Germany) in an optical microscope (40x
magniﬁcation lens). The adherence indexes (AI) were
cal-culated as follows: AI = 100 − [macrophages/mL super-
natant)/(macrophages/mL original sample)] × 100.
4.9. Determination of Chemotactic Index (CI). The chemo-
tactic indexes of peritoneal macrophages were determined
according to Wilkinson with slight modiﬁcation [46]. Three
small circular wells were punched out equidistantly in
0.8% agar gel. The central well was ﬁlled with peritoneal
macrophages (5 × 104/well). One of the peripheral wells was
ﬁlled in PBS IX and the other with fMLP (10−8 M ) ,aw e l l -
known chemoattractant. The chemotactic factor present in
the fMLP diﬀuses radially through the agar and attracts the
macrophagestowardthefMLP.Cells wereaspirated at15, 30,
60, and 90min from both the peripheral wells of each plate
and smears were drawn separately on glass slides, allowed
to air-dry, ﬁxed in methanol, and stained with Giemsa.
Chemotactic index of the respective groups was determined
from the ratio of directed migration; that is, cells migrated
toward the fMLP containing well to random migration; that
is, cells migrated toward the PBS-containing well.
4.10. Determination of Phagocytic Index (PI). Phagocytosis
assayofinertparticles(latexbeads)wascarriedoutfollowing
the method of De la Fuente [47]. Aliquots of 200μL of the
peritoneal suspension were incubated in cell culture plates
(Tarson) for 30min. The adhered monolayer obtained was
washed with prewarmed PBS, and then 200μLo fH a n k ’ s
medium and 20μL latex beads (diameter: 1.09μm) (Sigma)
were added. After 30min of incubation, the plates were
washed, ﬁxed, and stained, and the number of particles
ingested by 100 macrophages was determined by counting
in an optical microscope (100x magniﬁcation lens). The
number of ingesting macrophages per 100 macrophages was
also determined.
4.11. Determination of Intracellular Killing Activity (IKA).
Staphylococcus aureus bacteria (107/mL) were incubated
with macrophages (106/mL) in a total volume of 1mL
RPMI-BSA containing 10% normal mouse serum and this
bacteria/macrophage preparation was rotated for 20min at
37◦C. Noningested bacteria were removed by diﬀerential
centrifugation(10min,900rpm)at4◦Candtwowasheswith
ice-cold RPMI-BSA. The cells containing ingested bacteria
were resuspended in RPMI-BSA containing 10% normal
mouse serum and then reincubated at 37◦C( i np r e s e n c e
of 100μg/mL gentamycin to kill extra cellular bacteria) for
1h. Cells were washed in RPMI-BSA to remove gentamycin.
After washing, cells were reincubated for 1h and during
this incubation cells were taken at diﬀerent time intervals,
keeping the cells in ice followed by centrifugation termi-
nated intracellular killing. After addition of distilled water
containing 0.01%BSA to the pellet, cells were disrupted
by vigorously vortexing to release intracellular bacteria in
the supernatant. 0.1mL of the supernatant was serially
diluted in sterile distilled water and plated onto nutrient
agartodeterminethenumberofviableintracellularbacteria.
The number of colonies obtained at the beginning of the
experiment (0min after reincubation) was designated as
given by 100% viable bacteria. Intracellular killing was then
expressed as the percentage decrease from the initial number
of viable bacteria [48].
4.12. Measurement of Cytokine Release by Sandwich ELISA.
The level of murine TNF-α, IL-12p70, IL-10, and TGF-
β in the conditioned medium of macrophage culture was
measured using a sandwich ELISA Kit (Quantikine M; R&D
systems). The assay was performed as per the detailed
instructionsofthemanufacturer.Thedetectionlimitofthese
assays was <5.1, <2.5, <4, and <3pg/mL for TNF-α,I L -
12p70, IL-10, and TGF-β,r e s p e c t i v e l y .
4.13. Isolation of RNA and Real-Time PCR. Total RNA was
extractedfrom4 ×106 murineperitonealmacrophagesusing
TRI Reagent (Sigma) according to the manufacturer’s pro-
tocol. Isolated total RNA (1μg) was then reverse transcribed
usingRevertAidM-MuLVReverseTranscriptase(Fermentas,
USA). The resulting cDNA was then used for real-time PCR
for iNOSII and cytokines (IL-12p40, TNF-α, IL-10, and
TGF-β) using an ABI 7500 real-time PCR system (Applied
Biosystems, UK) with the DNA binding SYBR green dye.
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was
used as a reference. The forward and reverse speciﬁc primer
sequences used were as follows:
iNOSII:
forward5 -CCCTTCCGAAGTTTCTGGCAGCAGC-
3 ,
reverse 5 -GGCTGTCAGAGCCTCGTGGCTTTGG-
3 ;
TNF-α:
forward 5 -GGCAGGTCTACTTTGGAGTCATTGC-
3 ,
reverse 5 -ACATTCGAGGCTCCAGTGAATTCGG-
3 ;
IL-12p40:
forward 5 -CAACATCAAGAGCAGTAGCAG-3 ,
reverse 5 -TACTCCCAGCTGACCTCCAC-3 ;Oxidative Medicine and Cellular Longevity 9
IL-10:
forward 5 -CGGGAAGACAATAACTG-3 
reverse 5 -CATTTCCGATAAGGCTTGG-3 ;
TGF-β:
forward 5 -GGATACCAACTATTGCTTCAGCTCC-
3 ,
reverse 5 -AGGCTCCAAATATAGGGGCAGGGTC-
3 ;
GAPDH:
forward 5 -CAAGGCTGTGGGCAAGGTCA-3 ,
reverse 5 -AGGTGGAAGAGTGGGAGTTGCTG-3 .
For real-time quantitative PCR, each reaction contained
X 1 SYBR Green PCR master mixture (Power SYBR Green
P C RM a s t e rM i x ;A p p l i e dB i o s y s t e m s ,U K ) ,1 0p m o lo fe a c h
primer, and 1μLo fc D N Ai naﬁ n a lv o l u m eo f2 0μL. The
reaction conditions were as follows: initial activation step
(5min at 95◦C) and cycling step (denaturation for 30s at
94◦C, annealing for 30s at 58◦C and then extension for
1minat72 ◦C × 40cycles) followed by melt curve analysis.
Detection of the dequenched probe, calculation of threshold
cycles(Ctvalues),andfurtheranalysisofthesedatawereper-
formed by the Sequence Detector software. Relative changes
in iNOSII and cytokine (IL-12p40, TNF-α, IL-10, and TGF-
β) mRNA expression were compared with an unstimulated
control, normalized to GAPDH, and were quantiﬁed by
the 22
−ddCt method. Thus, all the values for experimental
samples were expressed as fold diﬀerences between the
sample mRNA and the calibrator (GAPDH) mRNA. The
data are presented as the mean ± S.E.M. of data from three
independent experiments that yielded similar results.
4.14. Densitometric Analysis. Gene expression data were
analyzed using a model GS-700 imaging densitometer and
Molecular Analyst version 1.5 software (Bio-Rad Laborato-
ries, Hercules, CA, USA).
5.StatisticalAnalysis
The experiments were performed three times and the data
are presented as mean ± S.E.M. Comparisons of the means
of control and experimental groups were made by two-
way ANOVA test (using a statistical package, Origin 6.1,
Northampton, MA 01060 USA) with multiple comparison
t-tests, P<0.05 as a limit of signiﬁcance.
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